180 related articles for article (PubMed ID: 21253761)
1. Identification of vitronectin as a novel serum marker for early breast cancer detection using a new proteomic approach.
Kadowaki M; Sangai T; Nagashima T; Sakakibara M; Yoshitomi H; Takano S; Sogawa K; Umemura H; Fushimi K; Nakatani Y; Nomura F; Miyazaki M
J Cancer Res Clin Oncol; 2011 Jul; 137(7):1105-15. PubMed ID: 21253761
[TBL] [Abstract][Full Text] [Related]
2. Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma.
Alper O; Stetler-Stevenson WG; Harris LN; Leitner WW; Ozdemirli M; Hartmann D; Raffeld M; Abu-Asab M; Byers S; Zhuang Z; Oldfield EH; Tong Y; Bergmann-Leitner E; Criss WE; Nagasaki K; Mok SC; Cramer DW; Karaveli FS; Goldbach-Mansky R; Leo P; Stromberg K; Weil RJ
Cancer Sci; 2009 Sep; 100(9):1748-56. PubMed ID: 19594548
[TBL] [Abstract][Full Text] [Related]
3. A multiparametric serum marker panel as a complementary test to mammography for the diagnosis of node-negative early-stage breast cancer and DCIS in young women.
Lacombe J; Mangé A; Bougnoux AC; Prassas I; Solassol J
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1834-42. PubMed ID: 24957886
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of G-CSF and IL-7 in Iranian breast cancer patients.
Bordbar E; Malekzadeh M; Ardekani MT; Doroudchi M; Ghaderi A
Asian Pac J Cancer Prev; 2012; 13(10):5307-12. PubMed ID: 23244154
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of endothelin-1 (ET-1) and its precursor (Big ET-1) in breast cancer early diagnosis.
Kalles V; Zografos GC; Provatopoulou X; Kalogera E; Liakou P; Georgiou G; Sagkriotis A; Nonni A; Gounaris A
Tumour Biol; 2012 Aug; 33(4):1231-6. PubMed ID: 22415226
[TBL] [Abstract][Full Text] [Related]
6. Multilectin affinity chromatography for characterization of multiple glycoprotein biomarker candidates in serum from breast cancer patients.
Yang Z; Harris LE; Palmer-Toy DE; Hancock WS
Clin Chem; 2006 Oct; 52(10):1897-905. PubMed ID: 16916992
[TBL] [Abstract][Full Text] [Related]
7. Calponin-h2: a potential serum marker for the early detection of human breast cancer?
Debald M; Jin JP; Linke A; Walgenbach KJ; Rauch P; Zellmer A; Fimmers R; Kuhn W; Hartmann G; Walgenbach-Brünagel G
Tumour Biol; 2014 Nov; 35(11):11121-7. PubMed ID: 25099617
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid.
Alexander H; Stegner AL; Wagner-Mann C; Du Bois GC; Alexander S; Sauter ER
Clin Cancer Res; 2004 Nov; 10(22):7500-10. PubMed ID: 15569980
[TBL] [Abstract][Full Text] [Related]
9. Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ.
Takada K; Kashiwagi S; Asano Y; Goto W; Morisaki T; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
BMC Cancer; 2020 Jun; 20(1):513. PubMed ID: 32493410
[TBL] [Abstract][Full Text] [Related]
10. Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer.
Mangé A; Lacombe J; Bascoul-Mollevi C; Jarlier M; Lamy PJ; Rouanet P; Maudelonde T; Solassol J
Clin Cancer Res; 2012 Apr; 18(7):1992-2000. PubMed ID: 22322670
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
[TBL] [Abstract][Full Text] [Related]
12. Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry.
Li J; Orlandi R; White CN; Rosenzweig J; Zhao J; Seregni E; Morelli D; Yu Y; Meng XY; Zhang Z; Davidson NE; Fung ET; Chan DW
Clin Chem; 2005 Dec; 51(12):2229-35. PubMed ID: 16223889
[TBL] [Abstract][Full Text] [Related]
13. Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer.
Wang-Johanning F; Li M; Esteva FJ; Hess KR; Yin B; Rycaj K; Plummer JB; Garza JG; Ambs S; Johanning GL
Int J Cancer; 2014 Feb; 134(3):587-95. PubMed ID: 23873154
[TBL] [Abstract][Full Text] [Related]
14. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
Fredolini C; Pathak KV; Paris L; Chapple KM; Tsantilas KA; Rosenow M; Tegeler TJ; Garcia-Mansfield K; Tamburro D; Zhou W; Russo P; Massarut S; Facchiano F; Belluco C; De Maria R; Garaci E; Liotta L; Petricoin EF; Pirrotte P
Breast Cancer Res; 2020 Dec; 22(1):135. PubMed ID: 33267867
[TBL] [Abstract][Full Text] [Related]
15. Serum protein signature may improve detection of ductal carcinoma in situ of the breast.
Solassol J; Rouanet P; Lamy PJ; Allal C; Favre G; Maudelonde T; Mangé A
Oncogene; 2010 Jan; 29(4):550-60. PubMed ID: 19855429
[TBL] [Abstract][Full Text] [Related]
16. Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users.
Pitteri SJ; Amon LM; Busald Buson T; Zhang Y; Johnson MM; Chin A; Kennedy J; Wong CH; Zhang Q; Wang H; Lampe PD; Prentice RL; McIntosh MW; Hanash SM; Li CI
Cancer Res; 2010 Nov; 70(21):8598-606. PubMed ID: 20959476
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential breast cancer markers in nipple discharge by protein profile analysis using two-dimensional nano-liquid chromatography/nanoelectrospray ionization-mass spectrometry.
Kurono S; Kaneko Y; Matsuura N; Oishi H; Noguchi S; Kim SJ; Tamaki Y; Aikawa T; Kotsuma Y; Inaji H; Matsuura S
Proteomics Clin Appl; 2016 May; 10(5):605-13. PubMed ID: 26970563
[TBL] [Abstract][Full Text] [Related]
18. Vitronectin: a promising breast cancer serum biomarker for early diagnosis of breast cancer in patients.
Hao W; Zhang X; Xiu B; Yang X; Hu S; Liu Z; Duan C; Jin S; Ying X; Zhao Y; Han X; Hao X; Fan Y; Johnson H; Meng D; Persson JL; Zhang H; Feng X; Huang Y
Tumour Biol; 2016 Jul; 37(7):8909-16. PubMed ID: 26753956
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the differences of serum protein mass spectrometry in patients with triple negative breast cancer and non-triple negative breast cancer.
Liu AN; Sun P; Liu JN; Yu CY; Qu HJ; Jiao AH; Zhang LM
Tumour Biol; 2014 Oct; 35(10):9751-7. PubMed ID: 24972967
[TBL] [Abstract][Full Text] [Related]
20. Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer.
López-Árias E; Aguilar-Lemarroy A; Felipe Jave-Suárez L; Morgan-Villela G; Mariscal-Ramírez I; Martínez-Velázquez M; Alvarez AH; Gutiérrez-Ortega A; Hernández-Gutiérrez R
Electrophoresis; 2012 Jul; 33(14):2130-7. PubMed ID: 22821488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
